Circ Res. 2025 Nov 14. doi: 10.1161/CIRCRESAHA.125.326357. Online ahead of print. ABSTRACT BACKGROUND: Patients with sepsis-induced acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) commonly …
Blood Vessel Thromb Hemost. 2025 Sep 10;2(4):100107. doi: 10.1016/j.bvth.2025.100107. eCollection 2025 Nov. ABSTRACT The pathogenesis of immune thrombocytopenia (ITP) is complex and incompletely understood. Multiple …
Clin Case Rep. 2025 Nov 11;13(11):e71441. doi: 10.1002/ccr3.71441. eCollection 2025 Nov. ABSTRACT [This corrects the article DOI: 10.1002/ccr3.71238.]. PMID:41235376 | PMC:PMC12611313 | DOI:10.1002/ccr3.71441
Surg Case Rep. 2025;11(1):25-0473. doi: 10.70352/scrj.cr.25-0473. Epub 2025 Nov 8. ABSTRACT INTRODUCTION: Tumor rupture with neuroblastoma is an uncommon but serious complication, particularly in high-risk …
BMC Psychiatry. 2025 Nov 13;25(1):1087. doi: 10.1186/s12888-025-07532-6. ABSTRACT BACKGROUND: Mental disorders in children and adolescents are widespread and can have lasting effects on their emotional, …
Schizophrenia (Heidelb). 2025 Nov 13;11(1):135. doi: 10.1038/s41537-025-00681-3. ABSTRACT Numerous aspects of depressive symptomatology in first-episode schizophrenia spectrum disorders (FES) remain unclear. Based on data from …
Soc Psychiatry Psychiatr Epidemiol. 2025 Nov 13. doi: 10.1007/s00127-025-03017-9. Online ahead of print. ABSTRACT PURPOSE: Improving population mental health will require greater investment in prevention, …
Lancet Psychiatry. 2025 Dec;12(12):906-920. doi: 10.1016/S2215-0366(25)00296-2. ABSTRACT BACKGROUND: There are no pharmacotherapies available for cognitive impairment associated with schizophrenia (CIAS). The CONNEX programme investigated the …
BMJ Glob Health. 2025 Nov 13;10(11):e017276. doi: 10.1136/bmjgh-2024-017276. ABSTRACT BACKGROUND: Unprecedented, forced displacement, especially from conflict and war areas, requires addressing resultant mental health issues. …
Lancet Psychiatry. 2025 Dec;12(12):893-905. doi: 10.1016/S2215-0366(25)00273-1. ABSTRACT BACKGROUND: Second-generation antipsychotics are widely used to treat patients with bipolar spectrum disorders and effectively manage mood symptoms …
